The company said reported net sales for Q3 2024 increased 1% compared with Q3 2023 to $3,998.5 million, and organic sales rose 4%. Organic sales for Global Industrial increased 2% to $1,975.9 million.

1. 01

   The company said reported net sales for Q3 2024 increased 1% compared with Q3 2023 to $3,998.5 million, and organic sales rose 4%. Organic sales for Global Industrial increased 2% to $1,975.9 million.

2. 02

   Ecolab said reported operating income for Q3 2024 rose 85% to $1,044.8 million, and net income attributable to Ecolab rose 82% to $736.5 million. Excluding special (gains) and charges and discrete tax items, adjusted diluted EPS increased 19% to $1.83.

3. 03

   The company said that, under the One Ecolab initiative announced on July 30, 2024, it expects restructuring costs of $175 million and special charges of $50 million by the end of 2027. It also estimated annualized cost savings in continuing operations of $225 million by 2027.

4. 04

   The company said it agreed to sell its global surgical solutions business on April 27, 2024, and the sale closed on August 1, 2024. It said it recorded a gain on the sale of $365.3 million ($264.2 million after tax) in 2024.

Key figures

Quarter ended September 30, 2024

Revenue

$4.0B

Operating income

$1.0B

Net income

$737M

EPS

$2.58

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.